全文获取类型
收费全文 | 197951篇 |
免费 | 20052篇 |
国内免费 | 8149篇 |
专业分类
耳鼻咽喉 | 761篇 |
儿科学 | 4644篇 |
妇产科学 | 1160篇 |
基础医学 | 16069篇 |
口腔科学 | 2120篇 |
临床医学 | 25143篇 |
内科学 | 27405篇 |
皮肤病学 | 1036篇 |
神经病学 | 11859篇 |
特种医学 | 8840篇 |
外国民族医学 | 103篇 |
外科学 | 24282篇 |
综合类 | 37786篇 |
现状与发展 | 28篇 |
一般理论 | 2篇 |
预防医学 | 13932篇 |
眼科学 | 2169篇 |
药学 | 19239篇 |
201篇 | |
中国医学 | 10490篇 |
肿瘤学 | 18883篇 |
出版年
2024年 | 305篇 |
2023年 | 3673篇 |
2022年 | 5075篇 |
2021年 | 9507篇 |
2020年 | 9031篇 |
2019年 | 7004篇 |
2018年 | 6816篇 |
2017年 | 7749篇 |
2016年 | 8136篇 |
2015年 | 8149篇 |
2014年 | 13279篇 |
2013年 | 14892篇 |
2012年 | 12253篇 |
2011年 | 13486篇 |
2010年 | 10800篇 |
2009年 | 10319篇 |
2008年 | 10240篇 |
2007年 | 10511篇 |
2006年 | 9525篇 |
2005年 | 8588篇 |
2004年 | 7046篇 |
2003年 | 6323篇 |
2002年 | 4759篇 |
2001年 | 4248篇 |
2000年 | 3603篇 |
1999年 | 2808篇 |
1998年 | 2266篇 |
1997年 | 2099篇 |
1996年 | 1758篇 |
1995年 | 1679篇 |
1994年 | 1468篇 |
1993年 | 1123篇 |
1992年 | 1075篇 |
1991年 | 839篇 |
1990年 | 745篇 |
1989年 | 678篇 |
1988年 | 582篇 |
1987年 | 516篇 |
1986年 | 445篇 |
1985年 | 586篇 |
1984年 | 404篇 |
1983年 | 275篇 |
1982年 | 305篇 |
1981年 | 281篇 |
1980年 | 239篇 |
1979年 | 191篇 |
1978年 | 127篇 |
1977年 | 108篇 |
1976年 | 87篇 |
1975年 | 61篇 |
排序方式: 共有10000条查询结果,搜索用时 296 毫秒
991.
目的:对非吸烟女性肺癌潜在相关基因进行生物信息学分析及功能预测,探讨非吸烟女性肺癌患者的发病机制及预后标志物。方法:选择从GEO数据库下载非吸烟女性肺癌患者的基因芯片并用GEO2R软件筛选出差异表达基因(differentially expressed gene,DEG),再利用STRING 在线分析软件对DEG 进行GO 和KEGG 分析以及蛋白互作(protein-protein interaction,PPI)网络分析,然后利用插件(M-CODE)对所有DEG进行可视化处理,筛选关键DEG,最后利用GEPIA及Kaplan-Meier plotter在线工具对关键DEG进行功能预测及预后分析。结果:共筛选出160 个DEG,其中上调54 个、下调106 个;GO分析其生物学功能主要与血管形成、单个生物细胞间黏附、GTPase活性正调控和信号转导密切相关(均P<0.05)。KEGG分析发现,可能主要与细胞黏附分子、白细胞迁移、紧密连接和胞吞作用相关(均P<0.05)。PPI 网络分析获得8 个关键DEG,分别是TIE1、PECAM1、VEGFD、ICAM2、ESAM、EMCN、ROBO4 和CLDN5。结论:TIE1、CLDN5、ICAM2、ESAM、VEGFD、ROBO4 可能是非吸烟女性肺癌发病机制的研究靶点,PECAM1、EMCN可能是预测非吸烟女性肺癌患者病情进展及预后的标志物。 相似文献
992.
Isabel Tol Elspeth Cumber Daphne Nakakande Silvana Wijaya Catherine Turberfield Abdul Badran Safia Siddiqui Prakhar Srivastava Bethany Chung Molly Dineen Cariosa Devlin Claire Worrall Rebecca Green Emily Bennett Elizabeth Golding Ashling Lillis Ami Sabharwal Andrew S. Protheroe Robert A. Watson 《European journal of cancer care》2020,29(3)
993.
994.
Yawen Gao Lihua Luo Yangchun Xie Yu Zhao Jie Yao Xianling Liu 《Molecular carcinogenesis》2020,59(5):503-511
Lung adenocarcinoma (LUAD), as a form of non-small cell lung cancer (NSCLC), is the most frequently diagnosed lung cancer worldwide. To date, a few biomarkers have been reported to provide valuable information in guiding LUAD treatment. The aim of our study was to explore the functional role of pyrroline-5-carboxylate reductase 1 (PYCR1) in LUAD. Based on Oncomine database, we found that PYCR1 was highly expressed in LUAD tissues. We also confirmed an abnormal increase of PYCR1 expression in LUAD cell lines and patients' tissues. Through Kaplan-Meier plotter database, we further studied the prognostic values of PYCR1. The outcomes indicated that overexpressed PYCR1 associated with poor prognosis among LUAD patients. To further study the function of PYCR1 in LUAD, cell counting kit-8, colony-forming, scratch wound healing, and Transwell assays were conducted. The results suggested that knockdown of PYCR1 curbed cell proliferation, migration, and invasion in LUAD cell lines. Subsequently, we identified 50 top genes positively and negatively correlated with PYCR1 in LUAD, and conducted biological pathway enrichment analysis of these genes. Among those enriched pathways, we selected JAK/STAT signaling pathway for further analysis. The results of Western blot assays revealed that PYCR1 knockdown significantly increased the expression of Bcl-2 and c-Myc, and the phosphorylation level of JAK2 and STAT3. Taken together, this study unearthed that PYCR1 knockdown could inhibit tumor growth and affect the JAK/STAT signaling pathway in LUAD. This study may contribute to a better understanding of PYCR1 in LUAD and provide a potential biomarker for cancer prognosis. 相似文献
995.
Recently, immunotherapy has evolved into a true treatment modality with the approval of PD-1 and PD-L1 inhibitors as the standard care for first-line treatment in patients with non-small cell lung cancer (NSCLC). Until now, for patients with advanced NSCLC, treatment of targeting immune checkpoints reveals a promising survival benefit, and some patients even get long term survive, which creates a paradigm shift in NSCLC treatment. However, many issues or problems are also appearing in clinical practice, such as the lower overall efficacy rate (20–40%), treatment modes, populations choice of immunotherapy, drug resistance, and safety, etc. Thus, in this review, we will mainly summarize and discuss the recent development and confusion of PD-1/PD-L1 inhibitors for advanced NSCLC patients based on current clinical studies. 相似文献
996.
Bobo H. P. Lau Ting-Kin Ng Yat-Lui Fung Tai-Chung Lam Tsz-Him So 《Journal of psychosocial oncology》2020,38(4):389-405
AbstractPurposes/objectives: This paper reports the comparative efficacies of integrative body-mind-spirit intervention (I-BMS) and cognitive behavioral therapy (CBT) in patient-caregiver parallel groups for Chinese patients with lung cancer.Design: Randomized controlled trial (RCT).Methods: One hundred and fifty-seven patient-caregiver dyads with no marked functional impairment were randomized into one of the two interventions with eight weekly patient-caregiver parallel groups. Assessments were conducted at baseline, within one, eight- and sixteen-weeks post-intervention. Effects of treatment group across time were analyzed by multilevel modeling.Findings: CBT led to greater reduction in emotional vulnerability than I-BMS. I-BMS resulted in greater increase in overall QoL and spiritual self-care, and more reduction in depression than CBT. Patients in both interventions experienced improvement in physical, emotional and spiritual, except social, domains of QoL.Conclusion: I-BMS was more efficacious for diverse domains of QoL, and CBT was more effective for emotional well-being, despite the relatively small between-group effect sizes.Implications for psychosocial providers/policy: (1) With the expanding repertoire of psychosocial interventions for families facing lung cancer, it has become imperative to investigate the comparative efficacies of empirically supported and culturally adapted interventions. (2) Our findings show that I-BMS was more effective for diverse domains of QoL, while CBT was more efficacious with emotional well-being, although both interventions led to significant improvements in physical, emotional and spiritual domains of patient QoL. (3) Patient-caregiver parallel groups have been shown to be effective for enhancing QoL of Chinese lung cancer patients. (4) Care professionals are encouraged to dispense interventions based on the idiosyncratic needs and preferences of the patients to maximize the treatment effects. 相似文献
997.
目的 探讨三连杆模型用于深蹲动作互动动力学分析的合理性,明确三连杆模型与Visual 3D计算关节力矩的差异来源。方法 选取8名受试者,通过Vicon获取深蹲动作运动学数据,采用拉格朗日第二类方程建立三连杆动力学方程,基于Mathematica编程计算获取关节力矩,与Visual 3D下肢链节段模型计算结果进行对比分析,并采用复相关系数(coefficient of multiple correlation, CMC)评价两者的相似程度。结果 8名受试者髋、膝关节CMC均大于0.85,踝关节CMC在0.50~0.85之间,三连杆动力学方程和Visual 3D计算的关节力矩在髋、膝关节处高度相似,在踝关节处仅呈现中度相似性。结论 三连杆模型可用于深蹲动作的关节力矩分析以及进一步的环节互动动力学分析,但应当考虑由地面反作用力引起的互动力矩(外力矩)对踝关节力矩的影响。 相似文献
998.
999.
1000.
《Clinical microbiology and infection》2020,26(2):240-246
ObjectivesWe aimed to characterize kinetics of non-treponamal antibody titres during the natural course of syphilis and explore their roles in monitoring syphilis treatment efficacy.MethodsSixty New Zealand white male rabbits were challenged with Nichols or Amoy Treponema pallidum strains, and the rapid plasma reagin (RPR) test was performed to quantify non-treponemal antibody titres during the infection course. Viable T. pallidum in the challenged rabbits was assessed with rabbit infectivity tests.ResultsThe RPR titres of the Nichols or Amoy strain between no benzathine penicillin G (BPG) and BPG treatment subgroups displayed a similar trend: first ascending and then descending. Compared with baseline, the proportions of fourfold decline in RPR titres in the Nichols or Amoy group presented a similar result on days 30, 60 and 180 between the no BPG and BPG treatment subgroups (0%, 0/5; 80%, 4/5; 100%, 5/5; vs. 0%, 0/5; 80%, 4/5; 100%, 5/5; p 0.999; 0%, 0/5; 80%, 4/5; 80%, 4/5; vs. 40%, 2/5; 100%, 5/5; 100%, 5/5; p 0.098, respectively). Compared with the maximum baseline titre, the proportion of fourfold decline in PRR titre also showed a similar result in the two groups on days 30, 60 and 180 between the no BPG and the BPG treatment subgroups (0%, 0/5; 100%, 5/5; 100%, 5/5, vs. 40%, 2/5; 100%, 5/5; 100%, 5/5; p 0.129; 0%, 0/5; 100%, 5/5; 100%, 5/5, vs. 80%, 4/5; 100%, 5/5; 100%, 5/5; p 0.091, respectively. Moreover, regardless of whether the RPR titres presented a fourfold decline, viable T. pallidum could be detected in untreated rabbits' lymph nodes at 30, 60 and 180 days post infection, while viable T. pallidum was not detected in any of the treated rabbits' lymph nodes.ConclusionsThe RPR titre increased and then decreased (even became negative) during the natural course of syphilis, similar to that seen after BPG treatment. The RPR tetre is thus a questionable indicator of syphilis treatment efficacy. 相似文献